Drugs / Mycophenolate mofetil (MMF)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00928018 Comparator | Jun 2009 → Nov 2014 | Hodgkins lymphoma, non-Hodgkin lymphoma | Dana-Farber Cancer Institute | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mycophenolate mofetil (MMF) | “Mycophenolate mofetil (MMF)” NCT00928018 ↗ |
| Known as | MMF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00928018 ↗ |
| Route | Intravenous | “3gm daily orally (or intravenously if the patient cannot tolerate oral administration)” NCT00928018 ↗ |
| Route | Oral | “3gm daily orally (or intravenously if the patient cannot tolerate oral administration)” NCT00928018 ↗ |